3.5051.27% ( -0.045 )
Delay Closed: Nov 16, 16:08:11Profile
About

INNOGEN-B
02591.HK
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drug engaged in the research, development and commercialization of pharmaceutical products. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity and overweight, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.
Profile
- Company Name
- Guangzhou Innogen Pharmaceutical Group Co., Ltd
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.innogenpharm.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
